Scintica and KA Imaging Announce New Partnership to Expand Access to Advanced X-ray Imaging Solutions for Preclinical Research

[March, 2026]
London, Ontario and Waterloo, Ontario – March 26, 2026 –

Scintica is pleased to announce a new partnership with KA Imaging to provide advanced X-ray imaging solutions for the preclinical and biomedical research community.

Down to 0.8 μm voxels at maximum magnification, KA Imaging’s inCiTe 3D X-ray Microscope will offer advanced capabilities to the preclinical and biomedical research community.

This partnership brings together Scintica’s established expertise in preclinical research technologies and customer support with KA Imaging’s innovation in advanced X-ray technology. Together, the two companies aim to provide researchers with access to imaging solutions that support high-quality scientific investigation and translational research.

“We are excited to partner with KA Imaging and bring the inCiTe 3D X-ray Microscope to the preclinical research market,” said Blair Poetschke, President of Scintica. “This partnership reflects our ongoing commitment to providing researchers with innovative technologies that support scientific discovery. We believe KA Imaging’s solutions will be a valuable addition to our portfolio and to the laboratories we serve.”

“Our partnership with Scintica connects KA Imaging to a broad North American network and the biomedical research community. By bringing together phase-contrast imaging with inCiTe and high-resolution amorphous selenium technology with BrillianSe, we’re helping advance research and science.” said Jim Harp, Vice President of NDT Sales & Business Development.

“At Scintica, we are focused on identifying technologies that deliver meaningful value to researchers and align with the evolving needs of the preclinical imaging market,” said Jade Marrow, Senior Product Manager at Scintica. “The addition of KA Imaging’s inCiTe 3D products strengthens our ability to support customers with advanced X-ray imaging solutions and broaden the range of tools available for preclinical and biomedical applications.”

The partnership reflects a shared commitment to advance research through innovative imaging technologies and strong scientific collaboration.

For more information, visit Scintica.com and kaimaging.com.